Memorial Şişli Hospital
Memorial Şişli Hospital
Turkey, Istanbul
Betul Tavil
29 years of experience
accreditations :
Clinic is certified :
Stem cell therapy for COPD in Turkey typically costs from AUD $17,144 to AUD $28,573. Prices depend on cell concentration, administration methods, and the number of sessions required. Patients save around 12% compared to Australia, where costs average AUD $19,572. Packages usually include pulmonary specialist consultations, laboratory processing, hospital stays, airport transfers, and translation services.
Bookimed Expert Insight: Choosing JCI-accredited facilities in Istanbul provides high-standard care at competitive rates. For instance, Memorial Şişli Hospital was the first in Turkey to earn this international accreditation. Some protocols at Liv Hospital Ulus include advanced exosome treatments to enhance results. Expert pulmonologists like Dr. Mehmet Aydogan have published over 40 international papers on respiratory diseases. This academic expertise ensures patients receive protocols based on the latest clinical evidence.
| Turkey | Thailand | ||
| Stem cell therapy for COPD | from AUD $17,144 | from AUD $17,144 | from AUD $9,286 |
Dr Irfan Eser is a highly trained thoracic surgeon based at the Medical Park Antalya Hospital Complex. He focuses on lung health and advanced surgical interventions for respiratory conditions.
Dr Mehmet Aydogan is a highly published chest specialist who authored the COPD chapter for Turkey's basic reference book for family practice.
Dr. Erdal Karaöz is a pioneer in regenerative medicine at Liv Hospital Ulus. He established the first private stem cell production center in Turkey under GMP standards. He previously conducted stem cell research at Harvard University in Boston. Dr. Karaöz founded the first institutional stem cell R&D center in Turkey at Kocaeli University.
Dr. Betul Tavil is a professor of pediatric hematology and oncology at Memorial Şişli Hospital. She has successfully treated 500+ children with leukemia. Dr. Tavil is an expert in bone marrow transplantation for complex cases. She manages rare blood disorders, including congenital erythropoietic porphyria and immunodeficiencies. Memorial Şişli Hospital is JCI-accredited and maintains a 90% organ transplant success rate.
Stem cell therapy in Turkey manages COPD symptoms rather than providing a definitive cure. JCI-accredited centres use mesenchymal stem cells to reduce lung inflammation. This may slow disease progression. However, medical authorities do not recognise it as a complete reversal of lung damage.
Bookimed Expert Insight: Data suggests Istanbul is the primary hub. Specialists like Dr Irfan Eser hold memberships in the European Respiratory Society. Prices range from $12,000 to $20,000. Patients should choose clinics with dedicated pulmonology departments rather than general wellness centres.
Patient Consensus: Many travellers to Turkey report modest improvements in daily breathing and energy. Most advise having a local GP in Australia ready to coordinate follow-up care. This helps manage expectations regarding long-term results.
Suitable candidates for COPD stem cell therapy in Turkey are typically non-smokers with moderate stage 2 or 3 disease. Ideal patients maintain lung function (FEV1) between 30% and 60%.
Bookimed Expert Insight: Bookimed data shows Turkey is a leading destination with 390 clinics and 11,700 requests served. Major centres like Liv Hospital Ulus and Memorial Şişli Hospital hold JCI accreditation. This confirms Australian patients receive care at facilities meeting rigorous international safety standards.
Patient Consensus: Patients suggest that fitness for international travel is just as important as lung function. They also recommend having your detailed diagnostic history ready before checking suitability in Turkey.
Clinics in Turkey deliver stem cell therapy for COPD using specialised protocols. These combine intravenous infusion with interventional bronchoscopy. These procedures target lung tissue repair at Joint Commission International (JCI) accredited hospitals in Istanbul. They typically use mesenchymal stem cells (MSCs) known for their anti-inflammatory properties.
Bookimed Expert Insight: Many centres offer standard intravenous infusions. However, top-tier Turkish hospitals frequently integrate endobronchial ultrasonography (EBUS). This allows doctors to monitor airway health in real-time while delivering cells. For patients, this precision-guided approach helps cells reach areas of high inflammation more effectively.
Patient Consensus: Patients in Turkey often highlight the importance of knowing the cell source. They recommend checking if the clinic uses their own cells or donor cells. Many suggest requesting written protocols that detail delivery methods and follow-up care.
Istanbul and Antalya are the primary regions in Turkey for stem cell therapy for COPD. These hubs house major JCI-accredited hospitals such as Liv Hospital Ulus and Medical Park Antalya. Specialists like Dr Mehmet Aydogan and Dr Irfan Eser treat international respiratory patients at these centres.
Bookimed Expert Insight: Istanbul serves the most patients, but Antalya is an emerging hub for respiratory care. Data shows clinics there often integrate thoracic surgery expertise with regenerative medicine. This dual-specialisation is crucial for patients with complex COPD who need surgical and cellular approaches.
Patient Consensus: Focus searches on private hospital groups in Istanbul for the most documented stem cell protocols. Patients value clinics that provide English-language medical reports and clear telehealth support after returning home.